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Ninety-seven Years Old Hispanic Male With 
Mantle Cell Lymphoma
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Abstract
Treating geriatric patients can be difficult. Patients often present 
with subtle or atypical symptoms, and end-of-life care is rarely 
neatly packaged. We present a case of a 97 years old Hispanic male 
with multiple medical problems who was diagnosed with mantle 
cell lymphoma after thoracentesis from what was thought to be 
a  para-pneumonic  effusion. An  oncology  evaluation  determined 
that he was not a candidate for aggressive treatment. There is no 
evidence of curative treatment for mantle cell lymphoma. To com-
plicate the decision making process further, the patient’s primary 
caregiver requested specifically that the health care team withholds 
the diagnosis from the patient. We discuss the inherent difficulties 
associated with end-of-life care.
Keywords: Geriatrics; End-of-life care; Mantle cell lymphoma; 
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Introduction
Mantle  cell  lymphoma  (MCL)  is  classified  by  the World 
Health  Organization  as  a  predominantly  nodal  mature  B 
cell non-Hogdkins lymphoma (NHL). It can be an aggres-
sive form of mature B cell lymphoma with a median sur-
vival of about 3 years [1, 2]. Risk factors for NHL include 
HIV, HTLV, EBV, H pylori infections, autoimmune diseases, 
congenital immunodeficiencies, and exposure to agricultural 
herbicides and pesticides or industrial solvents [3].  
MCL often presents in late stages. Median age of diag-
nosis is 60 to 68. Patients typically (75%) initially present 
with lymphadenopathy, but can also present with extranodal 
disease. Common sites of involvement include the lymph 
nodes, spleen, Waldeyer’s ring, bone marrow, blood, and ex-
tranodal sites, such as the gastrointestinal tract. One third of 
patients present with B symptoms of fever, night sweats and 
unintentional weight loss [2].  
Our case highlights two important issues when treating 
geriatric patients with different cultural backgrounds. The 
first problem was the difficulty of diagnosis in an elderly 
male patient with multiple co-morbid conditions. The patient 
presented with shortness of breath and weakness which was 
suspected to be pneumonia with a para-pneumonic effusion. 
After thoracentesis, he was diagnosed with mantle cell lym-
phoma. 
The  second  obstacle  was  communicating  effectively 
with the patient and his daughter, the surrogate medical deci-
sion maker and primary caregiver. She informed the team 
that her father did not want to know of his diagnosis. This 
raised many ethical questions of how to treat the patient ag-
gressively or refer for hospice effectively. 
 
Case Report
The patient was a 97 years old Hispanic male who was ad-
mitted to the hospital with shortness of breath and increasing 
fatigue. Two weeks prior to the current symptoms, the patient 
had been admitted, diagnosed with pneumonia, treated with 
antibiotics and then discharged home. Pertinent past medical 
history included hypertension, chronic obstruction pulmo-
nary disease, anemia, recurrent clostridium difficile colitis, 
chronic kidney disease, osteoarthritis, cerebrovascular acci-
dent without deficit, hyperlipidemia, cholelithiasis, nephro-
lithiasis, abdominal aortic aneurysm, and colon polyps. Of 
note, the patient had been hospitalized 9 times in the past 12 
months. Past surgical history included an appendectomy, re-
pair of abdominal aortic aneurysm, and colonoscopy 2 years 
prior with unknown results. He had an allergy to penicillin. 
Family  history  was  noncontributory.  Current  medications 
included moxifloxacin day 5, metroniadazole, amlodipine, 
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omeprazole and losartan. Review of systems revealed weight 
loss, abdominal pain, and back, hip and leg pain.
Vital signs on admission were unremarkable. Remark-
able  examination  findings  included  cachexia,  scleral  ic-
terus, white coating on tongue, bibasilar rhonchi, rales and 
wheezes, diffuse bilateral lower quadrant pain, guiaic posi-
tive stool, and tenderness in the lumbar and gluteal regions. 
There was no evidence of lymphadenopathy.   
Initial laboratory data revealed white blood cell count 
12,200,  hemoglobin  7.1,  hematocrit  22.7,  and  platelets 
291,000. Chemistry profile revealed BUN (blood urea nitro-
gen) 24, creatinine 1.34, glucose 134, and calcium 10.9. The 
remainder was unremarkable. 
Chest  radiograph  on  admission  noted  mild  bilateral 
pleural effusions, left greater than right with bibasilar air dis-
ease not significantly changed from the week prior.  
The patient was admitted with the following diagno-
ses: acute on chronic anemia secondary to a gastrointestinal 
bleed, pneumonia, chronic kidney disease, chronic obstruc-
tive pulmonary disease exacerbation, and oral candidiasis.   
Over the next several days, as his multiple medical prob-
lems were addressed, the team noted a persistent left pleural 
effusion. A pulmonology consult was requested and thora-
centesis performed. Pleural fluid analysis returned with fea-
tures consistent with mantle cell lymphoma. FISH analysis 
was positive for a clonal BCL-1/IgH gene rearrangement. 
Flow cytometry revealed Kappa monoclonal B-lymphocytes 
co-expressing CD5 and CD19 with no CD23 expression. 
Cyclin D1 translocation was positive as well. At this point, 
hematology and palliative care consults were requested.   
Computed  tomography  (CT)  scan  of  chest,  abdomen 
and pelvis revealed mediastinal adenopathy, diffuse gastric, 
pyloric and proximal duodenal wall thickening, as well as 
possible metastatic lesions in the pelvis with multiple ill-
defined lucencies. Final diagnosis was metastatic Stage IV 
(Ann Arbor) Mantle cell lymphoma. With our patient’s ad-
vanced age, debilitated state and multiple medical problems, 
all members of the medical care team agreed with a hospice 
referral. The care team presented the recommendation to the 
patient’s caregiver. 
The primary care and the palliative care team met with 
the patient’s daughter several times during the hospitaliza-
tion  to  discuss  her  father’s  diagnosis  and  prognosis. The 
team struggled to elucidate the role of hospice for her and, 
through her, for the family members not present. Family dy-
namics played a major role in the primary caregiver’s am-
bivalence toward hospice. Hospice was presented as a way 
for her father to stay at home and continue to be comfort-
able. She would have to help as necessary. The patient was 
discharged home to the care of his daughter and hospice. He 
is currently still alive and receiving regular physician home 
visits. He has not been told about the nature of his diagnosis. 
When the patient was asked by his PCP if he wanted to know 
the diagnosis, he continued to refer to his oldest daughter.
Discussion
  
This case highlights two common problems in geriatric med-
icine. One is the difficulty in sorting through multiple medi-
cal problems to arrive at a relatively uncommon diagnosis, 
as the patient did not present with classic lymphadenopathy 
or have all the B symptoms.  
The other challenge was interacting with the patient and 
family to make the best quality of life decision for the patient. 
The most important risk factor for poor prognosis in MCL is 
age more than 60 years. However, age should not be the only 
reason to avoid aggressive treatment. Other prognostic indi-
cators include elevated serum lactate dehydrogenase level, 
advanced stage disease, decreased functional performance, 
hemoglobin, gender, and more than one site of extranodal 
disease [3]. There are several studies indicating that older 
adults in otherwise good health can tolerate the effects of the 
treatment which includes chemotherapy, radioimmunother-
apy, and hematopoietic stem cell transplantation. However, 
there is no evidence for a cure [4, 5].
There are inherent conflicts that arise during these dis-
cussions. Caregivers need time to see how the patient is pro-
gressing, time to discuss matters with other family members, 
and time to grieve over the prospect of losing a family mem-
ber. Physicians and hospitals are motivated to make deci-
sions rapidly and move the patient to the final disposition.  
Attitudes toward end-of-life care differ between ethnic 
groups which can be complicated by differences in ethnicity 
of the physicians as well. While most patients in all ethnic 
groups in a medicare survey wished to die at home, a higher 
percentage of Hispanic patients versus non-Hispanic Whites 
wanted to die in the hospital, who would tolerate drugs that 
entailed daily suffering to prolong life and wanted mechani-
cal ventilation for life extension [6].  
Braun et al discussed the challenges that health care sur-
rogates have at the end of life. All ethnic/racial groups re-
ported a tremendous burden. This was worsened if the prog-
nosis was unclear and if the patient’s wishes were not known. 
If the surrogate could refer to the patient’s previously stated 
wishes, this burden was eased. Surrogate health care deci-
sion makers report a tremendous amount of stress involved 
in making the perceived ‘right’ decision and the possibility 
of being judged by other family members later [7].
A review of the literature performed by Kwak et al re-
vealed that Hispanics are more likely to have advance direc-
tives than African-Americans, but less likely than Caucasians 
or Asian-Americans. Although all groups were found to have 
misconceptions about advance directives, Caucasians typi-
cally were more aware of advance directives. Some ethnic 
groups, such as Chinese and Navajo, were opposed to the 
discussion of death because of the perceived negativity in-
herent in the topic. Regarding life support, Hispanics tend to 
be more likely than Caucasians to prefer life support. In this 
paper, Koreans and Mexican-Americans tended to not want 
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to be told of their diagnosis [8].    
Hispanics prefer family-centered decision making. They 
are less likely to name only one health care proxy because it 
may exclude other members of the family. They were found 
to expect the adult children to formulate the decisions, thus 
removing the burden from the patient. This was born out with 
our patient and his family. With the removal of the burden 
from the patient, it gets squarely placed with the caregiver. In 
Hispanic families, this is most likely a daughter. Asian fami-
lies tended to rely on their oldest son and daughter-in-law. 
Caucasians are most likely to rely on a spouse and African-
Americans a family member [8, 9].
Conclusions
This case stresses common challenges of working with el-
derly patients of various cultural backgrounds. Malignancy 
must be considered in a patient who is elderly and debilitat-
ed, even in the presence of multiple co-morbidities. A more 
timely diagnosis may not have changed our patient’s prog-
nosis, but it could have saved him and his daughter multiple 
hospitalizations.
It is important to be sensitive to the needs of the family, 
especially the surrogate decision makers. Some prior knowl-
edge of the cultural specifics can be helpful. Ideally, end-of-
life decisions would be discussed prior to a major life short-
ening illness. The families of patients need time: to process 
their feelings of grief and loss, to understand a confusing or 
changing diagnosis, to communicate with other family mem-
bers who may or may not be supportive of their decisions. It 
is important for the health care team to appreciate the fluidity 
of the family’s response. This requires patience and practice 
speaking in clear terms. Taking these steps may make the 
experience more satisfying for both physicians and patients 
as well as patients’ families.
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